Institut Pasteur, Université de Paris, Unité Plasticité du Génome Bactérien, et CNRS, UMR3525, 28 Rue du Dr Roux, F-75015 Paris, France.
Instituto de Bioquímica Vegetal y Fotosíntesis, CSIC and Universidad de Sevilla, Américo Vespucio 40, E-41092 Seville, Spain.
ACS Synth Biol. 2023 Feb 17;12(2):618-623. doi: 10.1021/acssynbio.2c00477. Epub 2023 Jan 27.
Inteins are proteins embedded into host proteins from which they are excised in an autocatalytic reaction. Specifically, split inteins are separated into two independent fragments that reconstitute the host protein during the catalytic process. We recently developed a novel strategy for the specific killing of pathogenic and antibiotic resistant bacteria based on toxin-intein combinations. Bacterial type II toxin-antitoxin systems are protein modules in which the toxin can provoke cell death whereas the antitoxin inhibits toxin activity. Although our previous system was based on a split intein (iDnaE) and the CcdB toxin, we demonstrated that iDnaE is able to reconstitute four different toxins. To expand the applicability of our system by widening the repertoire of toxin-intein combinations for complex set-ups, we introduced a second intein, iDnaX, which was artificially split. We demonstrate that iDnaX is able to reconstitute the four toxins, and we manage to reduce its scar size to facilitate their use. In addition, we prove the orthogonality of both inteins (iDnaE and iDnaX) through a toxin reconstitution assay, thus opening the possibility for complex set-ups based on these toxin-intein modules. This could be used to develop specific antimicrobial and other biotechnological applications.
内肽酶是嵌入宿主蛋白中的蛋白质,它们通过自动催化反应从宿主蛋白中被切割出来。具体来说,分裂内肽酶被分成两个独立的片段,在催化过程中重新组成宿主蛋白。我们最近开发了一种基于毒素-内肽酶组合的特异杀伤致病和耐药菌的新策略。细菌 II 型毒素-抗毒素系统是一种蛋白质模块,其中毒素可以引发细胞死亡,而抗毒素则抑制毒素活性。尽管我们之前的系统基于分裂内肽酶(iDnaE)和 CcdB 毒素,但我们证明 iDnaE 能够重新组成四种不同的毒素。为了通过扩大毒素-内肽酶组合的范围来拓宽复杂设置的适用性,我们引入了第二个内肽酶 iDnaX,它是人为分裂的。我们证明 iDnaX 能够重新组成这四种毒素,并设法减小其疤痕大小以方便它们的使用。此外,我们通过毒素重组测定证明了这两种内肽酶(iDnaE 和 iDnaX)的正交性,从而为基于这些毒素-内肽酶模块的复杂设置开辟了可能性。这可用于开发特定的抗菌和其他生物技术应用。